Akebia Therapeutics | AKBA - 员工 总数



金融业
股票价格
USD
资产
USD 376.57M
现金及等价物
USD 184.84M
销售成本
USD 10.34M
流动资产
USD 252.96M
流动负债
USD 162.94M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 32.61M
销售毛利
USD 47.28M
债务利息支出
4.83M
贷款资金
USD 48.25M
市值
USD 316M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 15.61M
贸易债权人
USD 21.19M
应收帐款人
USD 47.03M


员工 更改 日
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Akebia Therapeutics 167 37 2023-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amgen 28K 1.3K 2024-12
Ardelyx 395 128 2024-12
Astellas Pharma 13.64K 1.11K 2025-12
AstraZeneca USD 89.9K 6.4K 2023-12
Bayer 99.72K 1.65K 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Celltrion 1.07K 94 2015-12
Cspc Pharmaceutical CNY 23.5K 1.34K 2023-12
Dianthus Therapeutics 53 14 2023-12
Exelixis 1.15K 163 2025-12
Fresenius Medical Care 112.38K 7.83K 2023-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Ironwood Pharmaceuticals 267 48 2023-12
J&J 138.1K 6.2K 2024-12
Kangmei Pharma 6.37K 39 2022-12
Karyopharm Therapeutics 325 60 2023-12
Knight Therapeutics 698 38 2022-12
Laboratorios Farma 1.99K 242 2022-12
Lexicon Pharmaceuticals 285 150 2023-12
Malin Corporation 5 1 2022-12
Moderna 5.8K 200 2024-12
Nektar Therapeutics 137 79 2023-12
Organigram Holdings 1.14K 241 2025-12
Prothena 163 10 2024-12
PTC Therapeutics 939 49 2024-12
Qiagen NV USD 6.18K 150 2022-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sanofi 84.59K 3.41K 2024-12
Sarepta Therapeutics 1.37K 58 2024-12
Sartorius 15.94K 2.11K 2022-12
Sino Biopharmaceutical CNY 25.81K 466 2023-12
Tectonic Therapeutic 45 1 2023-12
Tilray USD 2.84K 192 2025-12
Vanda Pharmaceuticals 203 87 2023-12
Zz Pientze Pharmaceu 2.72K 129 2022-12